Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

J.M. Smucker, Amgen rise; Tiffany, Best Buy fall

08/25/2020 | 04:21pm EST

NEW YORK (AP) — Stocks that moved heavily or traded substantially Tuesday:

Immunovant Inc., up $1.18 to $34.66.

The biotechnology company reported encouraging results from a study of its potential treatment for a muscle fatigue condition.

Amgen Inc., up $12.65 to $248.22.

The biotechnology giant will be added to the Dow Jones Industrial Average on Aug. 31 as part of an index shakeup.

Medtronic Plc., up $2.46 to $102.59.

The medical device company handily beat Wall Street's fiscal first-quarter profit and revenue forecasts.

Children’s Place Inc., down $4.39 to $18.92.

The children’s clothing and accessories chain reported disappointing second-quarter earnings and revenue.

Tiffany & Co., down $5.04 to $121.99.

The jeweler's purchase by LVMH was pushed back three months to Nov. 24.

Best Buy Co., down $4.73 to $112.64.

The electronics retailer did not provide a financial forecast and warned its sales growth could slow during the third quarter.

Hormel Foods Corp., down $1.10 to $51.54.

The maker of Dinty Moore stew and Skippy peanut butter warned that it could have trouble meeting demand in the fourth quarter.

J.M. Smucker Co., up $7.76 to $120.75.

The maker of Jif peanut butter and Folgers coffee reported good quarterly earnings and raised its financial forecasts.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
AMGEN INC. 0.15% 226.91 Delayed Quote.-5.87%
BEST BUY CO., INC -0.87% 106.54 Delayed Quote.21.34%
IMMUNOVANT, INC. 1.43% 50.32 Delayed Quote.217.08%
THE JM SMUCKER COMPANY 1.40% 116.48 Delayed Quote.11.86%
TIFFANY & CO. 0.05% 131.39 Delayed Quote.-1.74%
All news about AMGEN INC.
12/03AMGEN : Foundation Announces Recipients of $5.25M to Support Social Justice and ..
PU
12/02Amgen Inc. - World's Leading Life Science Companies Now Enrolling COMMUNITY, ..
AQ
12/01Takeda Pharmaceutical Company Limited - World's Leading Life Science Companie..
AQ
12/01AMGEN : Announces New Data Being Presented At ASH 2020
AQ
11/30COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs
RE
11/30Covid r&d alliance launches trial of amgen, ucb, takeda drugs for hospitalize..
RE
11/28AMGEN : What's Next For U.S. Biosimilar Litigation
AQ
11/26AMGEN : to Present At The Evercore ISI Virtual HealthCONx Conference
AQ
11/25AMGEN : To Present At The Evercore ISI Virtual HealthCONx Conference
PR
11/25AMGEN : On Pace for Eight-Day Losing Streak, Longest Since October 2017 -- Data ..
DJ
More news
Financials (USD)
Sales 2020 25 380 M - -
Net income 2020 7 038 M - -
Net Debt 2020 18 313 M - -
P/E ratio 2020 19,2x
Yield 2020 2,81%
Capitalization 132 B 132 B -
EV / Sales 2020 5,93x
EV / Sales 2021 5,55x
Nbr of Employees 23 400
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 251,24 $
Last Close Price 226,91 $
Spread / Highest target 34,0%
Spread / Average Target 10,7%
Spread / Lowest Target -18,5%
EPS Revisions
Managers
NameTitle
Robert A. Bradway Chairman, President & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
Peter H. Griffith Chief Financial Officer
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN INC.-5.87%132 100
JOHNSON & JOHNSON2.15%392 249
ROCHE HOLDING AG-4.55%287 762
PFIZER, INC.8.00%222 836
NOVARTIS AG-11.95%206 585
MERCK & CO., INC.-10.45%206 071